Seeking Alpha

SNTS
Santarus, Inc.

5/26/2012, 2:48 PM ET
52wk high:
52wk low:
EPS:
PE:
Div Rate:
Yield:
Market Cap:
Volume:
SNTS Market Currents more »
SNTS Instablog posts more »
  • Santarus, Inc. (SNTS) Announces Inclusion Of UCERIS Phase III Extended Use Data In Presentation At Digestive Disease Week Meeting
    Mon, May 21 MissionIR Comment!
  • Santarus - SNTS - New Highs
    Mon, Jan 9 Jim Van Meerten Comment!
  • Santarus, Inc. (SNTS) and Pharming Group NV (PHARM) Disclose FDA Special Protocol Assessment
    Thu, Aug 4, 2011 MissionIR Comment!
  • Santarus, Inc. (SNTS) and Pharming Group NV (PHARM) Disclose FDA Special Protocol Assessment
    Thu, Aug 4, 2011 QualityStocks Comment!
  • Hot Stock Picks Tuesday 12-28-10
    Tue, Dec 28, 2010 BullRyder Comment!
Write a post on SNTS
SNTS StockTalks
SNTS vs. ETF Alternatives
Company Description

We are a specialty biopharmaceutical company focused on acquiring, developing and commercializing proprietary products that address the needs of patients treated by gastroenterologists, endocrinologists and other physicians.

Currently Marketed and Approved Products
Our commercial... More